ENTITY

Shire (SHPG US)

13
Analysis
Health CareJapan
SHIRE PLC is a global biotechnology group focused on serving people with rare diseases and other specialized conditions. The Company develops products across core therapeutic areas including hematology, immunology, neuroscience, ophthalmics, lysosomal storage disorders, gastrointestinal, internal medicine endocrine and hereditary angioedema, and in oncology.
more
12 May 2018 09:53

Japan Sector Weights: 3 Month % Change - Services ▲ Healthcare ▼ as Global Cyclicals Recover

THREE MONTH % CHANGE IN SECTOR WEIGHTS - The presentation here differs from our most recent sector weight insight (Japan Sector Weights) which...

Logo
106 Views
Share
09 May 2018 21:19

Takeda/Shire I : On Drug Deals and Deckchairs

What was rumored, approached, rejected, re-offered and rejected twice more, then agreed.... is now official. Takeda Pharmaceutical Co Ltd (4502 JP)...

Logo
587 Views
Share
08 May 2018 19:56

Takeda Acquires Shire for US$64 Billion – We Continue Our Support of the Deal

Takeda Pharmaceutical Co Ltd (4502 JP) acquiring Shire PLC (SHP LN) is the biggest overseas acquisition ever by a Japanese drugmaker – we continue...

29 Apr 2018 20:57

Japan Sector Weights : 3 Month Incremental Change - Domestic Sectors ▲ Global Sectors ▼

TOPIX SECTOR CLASSIFICATIONS ARE 50 YEARS OLD - The TOPIX 17 and TOPIX 33 Sectors that most analysts use to monitor sectoral performance were first...

Logo
164 Views
Share
bullishShire PLC
27 Apr 2018 09:18

Maintaining Our FVE for Shire and Takeda During Extended Offer Period

We’re not making any changes to our fair value estimates for Shire PLC (SHP LN) (GBP 48.90 per share/$205 per ADR) or Takeda Pharmaceutical Co Ltd...

Logo
131 Views
Share
x